Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina

Subjects: Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Subjects: Get full text

Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics by S. V. Ponomarenko

Subjects: “…epidemiology and pharmacoeconomics of diabetes mellitus…”
Get full text

An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics. by Chen Min, Mi Xue, Fei Haotian, Li Jialian, Zhang Lingli

“…<h4>Conclusions</h4>Evidence showed that pharmacoeconomic systematic reviews' methodology remained to be improved, and the quality assessment criteria were gradually unified. …”
Get full text

PHARMACOECONOMIC ANALYSIS OF EFFICACY OF DIFFERENT MODES OF ANTIBIOTIC PROPHYLAXIS IN CHOLECYSTECTOMY by A. N. Poborskiy, N. I. Ponamarev, Sh. D. Asutaev

Subjects: Get full text

Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases by A A Samsonov, V B Grechushnikov, D N Andreev, G L Iurenev, T I Korovina, Iu A Lezhneva, I V Maev

“…To estimate the pharmacoeconomic parameters of treatment in patients with Helicobacter pylori-associated diseases when using 6 eradication therapy (ET) regimens. …”
Get full text

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY by A. V. Rudakova, S. A. Protsenko, I. A. Koroleva

Get full text

Development of a pharmacoeconomic registry: an example using hormonal contraceptives by Annesha White, Meenakshi Srinivasan, La Marcus Wingate, Samuel Peasah, Marc Fleming

Subjects: “…Pharmacoeconomic registry…”
Get full text

The issues of safety and pharmacoeconomics in the management of chronic pain in the back and limbs by Vladimir Anatol'evich Parfenov, O N Gerasimova, Vladimir Anatolyevich Parfenov, O N Gerasimova

“…The paper reviews the data available in the literature on adverse reactions occurring with the use of NSAIDs, discusses the issues of pharmacoeconomics in the administration of various NSAIDs. …”
Get full text

The Importance of the Pharmacoeconomic Analyses in Drug Negotiation. A Farewell Editorial by Mario Eandi

Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Subjects: Get full text

Pharmacoeconomic analysis of using biological agents in the treatment of rheumatoid arthritis by I. I. Dyakov, D. V. Goryachev

“…By taking into account the fact that there are a few alternative biological agents for the treatment of rheumatoid arthritis (RA), the cost of an annual therapy cycle using the agents is greater than that of high-technology surgical interventions, and a pharmacoeconomic study substantiating the optimal choice of a specific drug has been conducted. …”
Get full text

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina

Subjects: Get full text

Pharmacoeconomic aspects of recurrent / refractory chronic lymphocytic leukemia treatment by A. V. Rudakova, E. A. Stadnik

“…Thereby, this regimen can be canceled if patients do not progress after 2 years from therapy start.The objective of the study was to assess the pharmacoeconomic aspects of therapy with venetoclax and rituximab combination in patients with recurrent / refractory CLL compared with ibrutinib monotherapy.Materials and methods. …”
Get full text

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas by Michele Basile, Ilaria Valentini, Roberto Attanasio, Renato Cozzi, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Paolo Cappabianca, Agostino Paoletta, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi, Enrico Papini, Americo Cicchetti

Get full text

How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea by SeungJin Bae, Joohee Lee, Eun-Young Bae

Get full text

Pharmacoeconomic analysis of ischemic stroke therapy in patients with arterial hypertension by Mashin V.V., Barashkov N.S., Pinkova E.A., Khayrullin R.M.

Subjects: Get full text

Russian registry of patients receiving rituximab: results of pharmacoeconomic analysis by V N Amirdjanova, D V Goryachev, Sh F Erdes, E A Aseeva, G V Lukina

Get full text

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review by T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev

“…<p>The article reviews the pharmacoepidemiological and pharmacoeconomic trials of antihypertensive therapy, conducted during the last decades inRussia. …”
Get full text

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET by R. I. Yagudina, V. G. Serpik

“…Abstract: the pharmacoeconomic study compared the standard drug therapy (vitamin D and phosphorbinders) of secondary hyperparathyroidism (SHPT) to the using a combination of Mimpara (Cinalcet), vitamin D and phosphorbinders in patients with end-stage renal disease on dialysis. …”
Get full text